Delivery Order SPE2DB24D3013-SPE2DB25FFNEF
Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $1,539.12 and a completion date of April 1, 2024. This contract is a firm fixed-price delivery order, with no set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $9,076.42 and a completion date of June 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a firm fixed price of $3,744.16 and a performance period ending on May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $19,275.47 and a completion date of December 10, 2024. It is a firm fixed-price contract for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product. The contract is not set aside for any specific business designation. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 4567504104 OPZELURA 1.5% CREAM 60GM. The fixed-price contract has a ceiling value of $3,908.60 and a period of performance through March 10, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to supply a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a ceiling value of $8,297.34 and a period of performance ending on May 16, 2025. The contract is a Firm Fixed Price (FFP) type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,359.03, is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a performance period through December 16, 2024 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $2,254.49 and a period of performance through June 9, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,491.88, is for the delivery of OPZELURA 1.5% cream, a pharmaceutical product, to support federal healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999, which provides a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPZELURA 1.5% cream. The contract has a ceiling value of $5,111.82 and an ultimate completion date of August 13, 2024. It was awarded on August 12, 2024 as a firm fixed-price contract. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...